Cargando…
Potential four-miRNA signature associated with T stage and prognosis of patients with pancreatic ductal adenocarcinoma identified by co-expression analysis
With a 5-year survival rate of only 8%, pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-associated mortality worldwide. Unfortunately, even following radical surgery, patient outcomes remain poor. Emerging as a new class of biomarkers in human cancer, microRNAs (miRNAs/...
Autores principales: | You, Lukuan, Wang, Jinliang, Zhang, Fan, Zhang, Jing, Tao, Haitao, Zheng, Xuan, Hu, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297786/ https://www.ncbi.nlm.nih.gov/pubmed/30483731 http://dx.doi.org/10.3892/mmr.2018.9663 |
Ejemplares similares
-
The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma
por: Ren, Le, et al.
Publicado: (2018) -
An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma
por: Makler, Amy, et al.
Publicado: (2022) -
Fibrosis-related miRNAs as serum biomarkers for pancreatic ductal adenocarcinoma
por: Suzuki, Rei, et al.
Publicado: (2017) -
Interrelationship between miRNA and splicing factors in pancreatic ductal adenocarcinoma
por: Supadmanaba, I Gede Putu, et al.
Publicado: (2021) -
Four-miRNA signature as a prognostic tool for lung adenocarcinoma
por: Lin, Yan, et al.
Publicado: (2017)